Cardiac parasympathetic activity in severe uncomplicated coronary artery disease

J Nolan1, A D Flapan, J Reid

  • 1University Department of Medicine, Royal Infirmary, Edinburgh.

Insights

This study found no evidence linking coronary artery disease to reduced cardiac parasympathetic activity in uncomplicated cases. Previous findings may be due to patient complications, not the disease itself.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Medical Pathophysiology

Background:

  • Previous research suggested a link between coronary artery disease and reduced cardiac parasympathetic activity.
  • These studies often included patients with complications that could confound autonomic function findings.

Purpose of the Study:

  • To investigate cardiac parasympathetic activity in patients with severe, uncomplicated coronary artery disease.
  • To determine if coronary artery disease independently affects parasympathetic function.

Main Methods:

  • Studied 44 patients with severe coronary artery disease but no complications (infarction, diabetes, hypertension).
  • Measured cardiac parasympathetic activity using 24-hour ambulatory electrocardiograms to assess heart rate variability.
  • Utilized a validated index based on successive RR interval differences (> 50 ms) to quantify parasympathetic activity.

Main Results:

  • Mean heart rate variability counts were within normal ranges for waking, sleeping, and 24-hour periods.
  • Fewer than 10% of patients showed reduced parasympathetic activity compared to normal controls.
  • No correlation was found between coronary artery disease severity, antianginal drug use, and cardiac parasympathetic activity.

Conclusions:

  • This study found no independent association between uncomplicated coronary artery disease and reduced cardiac parasympathetic activity.
  • The findings suggest that previously reported autonomic abnormalities may be linked to complications rather than coronary artery disease itself.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...